市場調査レポート

米国のヘルスケア市場におけるナノテクノロジー:2014年・2019年の市場予測

Nanotechnology in Health Care (US Market & Forecast)

発行 Freedonia Group 商品コード 118987
出版日 ページ情報 英文 351 Pages
納期: 即日から翌営業日
価格
こちらの商品の販売は終了いたしました。
Back to Top
米国のヘルスケア市場におけるナノテクノロジー:2014年・2019年の市場予測 Nanotechnology in Health Care (US Market & Forecast)
出版日: 2010年06月30日 ページ情報: 英文 351 Pages

当商品の販売は、2016年07月01日を持ちまして終了しました。

概要

米国におけるナノテクノロジー医療製品の需要は毎年17%以上増加し、2014年に751億米ドルとなる見込みです。

当レポートでは、米国の医療分野におけるナノテクノロジー市場について調査し、製品・アプリケーション別の需要実績および予測(2014年・2019年)を提供、最近の健康保険改革、全体的な薬剤および医療機器の規制動向、企業の市場シェア、市場参入企業のプロファイルなどについて分析しており、概略下記の構成でお届けいたします。

イントロダクション

第1章 エグゼクティブサマリー

第2章 市場環境

  • 概要
  • マクロ経済動向
  • 人口統計パターン
  • ヘルスケア動向
    • 健康保険と償還
    • 医療環境
    • 国の医療費
    • 医療施設・専門家
    • 患者の活動
  • 医療製品市場の見通し
    • 製薬・製剤
    • 手術器具・備品
    • 手術・医療機器
    • 医療用電気機器
    • 診断製品
    • その他の医療製品

第3章 医療用ナノマテリアル

  • 概要
  • モノクローナル抗体
  • 薬剤ナノ粒子
  • DNAマテリアル
  • 量子ドット
  • その他のナノマテリアル

第4章 ナノテクノロジーヘルスケアの概要

  • 概要
  • 製品アプリケーション
  • 規制
  • 投資
  • 米国の貿易機会
  • 国際的活動

第5章 ナノメディシン

  • 概要
  • モノクローナル抗体
  • ナノポリマーメディシン
  • 結晶ナノメディシン
  • リポソームナノメディシン
  • その他のナノメディシン

第6章 ナノ診断

  • 概要
  • 体外ナノ診断
    • DNAベースのナノ診断
  • 体内ナノ診断
    • MRI造影剤
    • その他の体内診断

第7章 ナノテク医療用品・機器

  • 概要
  • 創傷管理製品
    • 閉包材
    • 被覆材
  • 代用骨
  • 歯科用製品
    • 製品グループ
    • サプライヤー
  • 手術用備品・機器
  • 医療インプラント
  • 眼科用製品
  • その他のナノテク医療用品・機器

第8章 アプリケーション

  • 概要
  • 中枢神経系疾患
  • 伝染病
  • 心血管疾患
  • その他

第9章 業界構造

  • 概要
  • 市場シェア
  • 競合戦略
  • ライセンシング契約
  • M&A
  • 研究開発
  • マーケティング・流通
  • 製造

企業プロファイル

図表

目次
Product Code: 2622

Abstract

US demand to rise more than 17% annually thru 2014

US demand for nanotechnology medical products will rise more than 17 percent per year to $75.1 billion in 2014. Going forward, the increasing flow of new nanomedicines, nanodiagnostics, and nanotech- based medical supplies and devices into the US marketplace will boost demand to $149 billion in 2019.

Nanomedicine market to reach $59 billion in 2014

The total market for nanomedicines will command strong growth over the long term, rising to almost $59 billion in 2014 and sustaining a strong upward pace through 2019. Treatments based on humanized monoclonal antibodies, nanopolymers and nanoproteins will drive gains, with compounds for cancer, heart diseases, neurological disorders and viral infections leading new product introductions and growth opportunities. Eventually, nanomedicines will extend into all major therapeutic classes, encompassing numerous formulations and delivery systems.

Nanodiagnostic products to grow nearly 7% annually

Among nanodiagnostic products, nanosized monoclonal antibody labels and DNA probes are greatly enhancing the speed, accuracy, capabilities and costeffectiveness of in vitro diagnostic testing, drug discovery and medical research procedures. Nanoparticle formulations of superparamagnetic iron oxide, gadolinium, perfluorocarbon and specialty polymers will broaden in vivo imaging capabilities by enabling the detection of tumors, plaque, genetic defects and other disease states at much earlier stages and with lower, safer concentrations of injected compounds. Reflecting anticipated performance advantages over existing products and an expanding range of new commercial offerings, demand for nanodiagnostics is projected to increase 6.8 percent per year to $11.3 billion in 2014, and continue rising at a good pace through 2019.

Nanotech supplies, devices to reach $5.1 billion in 2014

Within the medical supplies and devices segment, nanomaterials are already gaining significant demand as active ingredients of burn dressings, bone substitutes, and dental repair and restoration products. In the long term, advances in nanotechnology will lead to the introduction of new, improved medical supply and device coatings as well as a new, diverse group of medical implants. In 2014, demand for medical supplies and devices based at least partially on nanomaterials is projected to reach $5.1 billion, up from $530 million in 2009. This amount will more than triple by 2019 as nanotechnology-based orthopedic and cardiac implants and nanocoated medical and surgical instruments penetrate the marketplace.

Cancer among first disorders treated by nanotechnology

The greatest near-term impact of nanotechnology in health care by indication will be in therapies and diagnostics for cancer and central nervous system disorders. Gradually, many other major diseases, as well as injuries, will be treated and detected routinely by products based on nanosized ingredients. The nanotechnology segment of the medical product industry is divided among large multinational drug and medical supply companies, and research-oriented firms that develop commercial products or nanomaterials.

Study coverage

This new Freedonia industry study, Nanotechnology in Health Care, presents historical demand data plus forecasts for 2014 and 2019 by product type and application. The study also considers recent health insurance reforms and overall drug and medical device regulatory trends, evaluates company market share and profiles participants in the US industry.

Table of Contents

INTRODUCTION

I. EXECUTIVE SUMMARY

II. MARKET ENVIRONMENT

  • General
  • Macroeconomic Trends
  • Demographic Patterns
  • Trends in Health Care
    • Health Insurance & Reimbursement
    • Medical Conditions
      • Chronic Conditions
      • Acute Conditions
    • National Health Expenditures
    • Medical Facilities & Professionals
      • Acute Care Hospitals
      • Physicians
      • Outpatient Facilities
      • Skilled Nursing Homes
      • Dentists
    • Patient Activity
      • Hospital Activity
      • Surgical Procedures
      • Outpatient Activity
      • Diagnostic Tests
  • Medical Products Market Outlook
    • Pharmaceuticals & Biologicals
    • Surgical Appliances & Supplies
    • Surgical & Medical Instruments
    • Electromedical Equipment
    • Diagnostic Products
    • Other Medical Products

III. MEDICAL NANOMATERIALS

  • General
  • Monoclonal Antibodies
  • Drug Nanoparticles
  • DNA Materials
  • Quantum Dots
  • Other Medical Nanomaterials
    • Commercialized Materials
    • Dendrimers
    • Fullerenes
    • Nanotubes & Nanowires

IV. NANOTECHNOLOGY HEALTH CARE OVERVIEW

  • General
  • Product Applications
  • Regulation
    • Pharmaceuticals
    • Diagnostic Products
    • Medical Supplies & Devices
    • Current Good Manufacturing Processes
  • Investment
  • US Trade Opportunities
  • International Activities

V. NANOMEDICINES

  • General
  • Monoclonal Antibodies
    • Types of Monoclonal Antibodies
    • Marketed Products
    • Developmental Activities
  • Nanopolymer Medicines
    • Marketed Products
      • PEG-Based Nanomedicines
      • Other Nanopolymer Medicines
    • Developmental Activities
  • Crystalline Nanomedicines
    • Marketed Products
    • Developmental Activities
  • Liposomal Nanomedicines
    • Marketed Products
    • Developmental Activities
  • Other Nanomedicines
    • Marketed Products
    • Developmental Activities

VI. NANODIAGNOSTICS

  • General
  • In Vitro Nanodiagnostics
    • Monoclonal Antibody-Based Nanodiagnostics
      • Immunological Reagents
      • Cellular Analysis Reagents
      • Immunohematology Reagents
      • Research Reagents
    • DNA-Based Nanodiagnostics
      • Amplified DNA Probes
      • Direct DNA Probes
      • DNA Microarrays
      • Other DNA-Based Nanodiagnostics
  • In Vivo Nanodiagnostics
    • MRI Imaging Agents
      • Marketed Products
      • Developmental Products
    • Other In Vivo Nanodiagnostics

VII. NANOTECHNOLOGY MEDICAL SUPPLIES & DEVICES

  • General
  • Wound Management Products
    • Wound Dressings
    • Wound Closures
  • Bone Substitutes
  • Dental Products
    • Product Groups
    • Suppliers
  • Surgical Supplies & Devices
    • Surgical Textiles
    • Surgical Devices
  • Medical Implants
    • Orthopedic Implants
    • Cardiac Implants
    • Cochlear Implants
    • Other Medical Implants
  • Ophthalmic Products
    • Nanocoated Lenses
    • Drug Delivery Systems
    • Retinal Implants
  • Other Nanotechnology Medical Supplies & Devices
    • Catheters & Related Devices
    • Disinfectants
    • Artificial Skin

VIII. APPLICATIONS

  • General
  • Cancer
    • Epidemiological Trends
    • Nanomedicines
    • Nanodiagnostics
    • Nanotechnology Medical Supplies & Devices
  • Central Nervous System Conditions
    • Epidemiological Trends
    • Nanomedicines
    • Nanodiagnostics
    • Nanotechnology Medical Supplies & Devices
  • Infective Conditions
    • Epidemiological Trends
    • Nanomedicines
    • Nanodiagnostics
    • Nanotechnology Medical Supplies & Devices
  • Cardiovascular Conditions
    • Epidemiological Trends
    • Nanomedicines
    • Nanodiagnostics
    • Nanotechnology Medical Supplies & Devices
  • Other Applications
    • Ophthalmic Conditions
    • Medical Research & Drug Discovery
    • Respiratory Conditions
    • Endocrine Conditions
    • Gastrointestinal Conditions
    • Dermatological Conditions
    • All Other Applications

IX. INDUSTRY STRUCTURE

  • General
  • Market Share
  • Competitive Strategies
  • Licensing Agreements
  • Mergers & Acquisitions
  • Research & Development
  • Marketing & Distribution
  • Manufacturing

COMPANY PROFILES

  • Abbott Laboratories
  • Abraxis BioScience Incorporated
  • Access Pharmaceuticals Incorporated
  • Advion BioSciences Incorporated
  • Alexion Pharmaceuticals Incorporated
  • AMAG Pharmaceuticals Incorporated
  • Amgen Incorporated
  • Arrowhead Research Corporation
  • AstraZeneca plc
  • Bayer AG
  • BIOCIUS Life Sciences Incorporated
  • Biogen Idec Incorporated
  • Biophan Technologies Incorporated
  • BioTrove, see Life Technologies
  • Bristol-Myers Squibb Company
  • Calando Pharmaceuticals, see Arrowhead Research
  • Centocor Ortho Biotech Products, see Johnson & Johnson
  • Covidien plc
  • CritiTech Incorporated
  • Crystalplex Corporation
  • CytImmune Sciences Incorporated
  • Danaher Corporation
  • Dendritic Nanotechnologies, see Starpharma Holdings
  • Elan Corporation plc
  • Enzon Pharmaceuticals Incorporated
  • Flamel Technologies SA
  • Genentech, see Roche Holding
  • GlaxoSmithKline plc
  • ImClone Systems, see Lilly (Eli) and Company
  • Intradigm, see Silence Therapeutics
  • Johnson & Johnson
  • Kerr, see Danaher
  • Life Technologies Corporation
  • Lilly (Eli) and Company
  • Luna Innovations Incorporated
  • Merck & Company Incorporated
  • Mersana Therapeutics Incorporated
  • NanoBio Corporation
  • Nanobiotix SA
  • NanoCarrier Company Limited
  • NanoDel Technologies GmbH
  • NanoHorizons Incorporated
  • NanoInk Incorporated
  • NanoLab Incorporated
  • Nanospectra Biosciences Incorporated
  • Nanosys Incorporated
  • Nektar Therapeutics Incorporated
  • Novagali Pharma SA
  • Novartis AG
  • Novavax Incorporated
  • Orthovita Incorporated
  • Oxonica plc
  • Pfizer Incorporated
  • Pioneer Surgical Technology Incorporated
  • pSivida Corporation
  • Roche Holding Limited
  • Salvona Technologies Incorporated
  • Schering-Plough, see Merck & Company
  • Sensatex Incorporated
  • Siemens AG
  • SkyePharma plc
  • Smith & Nephew plc
  • Soliqs, see Abbott Laboratories
  • Spectrum Pharmaceuticals Incorporated
  • Starpharma Holdings Limited
  • Tego Biosciences, see Arrowhead Research
  • Teva Pharmaceutical Industries Limited
  • 3M Company
  • Wyeth, see Pfizer
  • Other Companies Mentioned in the Study

LIST OF TABLES

SECTION I -- EXECUTIVE SUMMARY

  • Summary Table

SECTION II -- MARKET ENVIRONMENT

  • 1 Macroeconomic Indicators
  • 2 Resident Population by Age Group
  • 3 Health Insurance Coverage of the US Population
  • 4 Chronic Conditions by Type
  • 5 Acute Conditions by Type
  • 6 National Health Expenditures
  • 7 Selected Medical Facilities & Professionals by Type
  • 8 Patient Activity by Type
  • 9 Medical Products Demand by Group

SECTION III -- MEDICAL NANOMATERIALS

  • 1 Medical Nanomaterials Demand by Type

SECTION IV -- NANOTECHNOLOGY HEALTH CARE OVERVIEW

  • 1 Nanotechnology Medical Products Demand by Group
  • 2 US Trade in Nanotechnology Medical Products
  • 3 World Demand for Nanotechnology Medical Products by Region

SECTION V -- NANOMEDICINES

  • 1 Nanomedicines Demand by Product Group
  • 2 Monoclonal Antibody Nanomedicines Demand by Indication
  • 3 Therapeutic Monoclonal Antibodies Approved for US Sale
  • 4 US Sales of Selected Therapeutic Monoclonal Antibodies, 2004 & 2009
  • 5 Nanopolymer Medicines Demand by Indication
  • 6 Polymer Nanomedicines Approved for US Sale
  • 7 US Sales of Nanopolymer Medicines, 2004 & 2009
  • 8 Crystalline Nanomedicines Demand by Indication
  • 9 Crystalline Nanomedicines Approved for US Sales
  • 10 Liposomal Nanomedicines Demand by Indication
  • 11 Other Nanomedicines Demand by Indication

SECTION VI -- NANODIAGNOSTICS

  • 1 Nanodiagnostics Demand by Product Group
  • 2 In Vitro Nanodiagnostics Demand by Product Group
  • 3 Monoclonal Antibody-Based Nanodiagnostics Demand by Type
  • 4 Monoclonal Antibody-Based Immunological Reagents Demand
  • 5 Monoclonal Antibody-Based Cellular Analysis Reagents Demand
  • 6 Monoclonal Antibody Immunohematology Reagents Demand
  • 7 Monoclonal Antibody-Based Research Reagents Demand
  • 8 DNA-Based Nanodiagnostics Demand by Type
  • 9 In Vivo Nanodiagnostics Demand by Product Group

SECTION VII -- NANOTECHNOLOGY MEDICAL SUPPLIES & DEVICES

  • 1 Nanotechnology Medical Supplies & Devices Demand by Product Group
  • 2 Nanotechnology Wound Management Products Demand by Type
  • 3 Nanotechnology Bone Substitutes Demand
  • 4 Nanotechnology Dental Products Demand by Group
  • 5 Nanotechnology Surgical Supplies & Devices Demand
  • 6 Nanotechnology Medical Implant Demand by Type
  • 7 Nanotechnology Ophthalmic Products
  • 8 Other Nanotechnology Medical Supplies & Devices

SECTION VIII -- APPLICATIONS

  • 1 Nanotechnology Medical Products Demand by Application
  • 2 Nanotechnology Medical Products Demand in Cancer Applications
  • 3 Nanotechnology Medical Products Demand in Central Nervous System (CNS) Applications
  • 4 Nanotechnology Medical Products Demand in Infective Condition Applications
  • 5 Nanotechnology Medical Products Demand in Cardiovascular Applications
  • 6 Nanotechnology Medical Products Demand in Other Applications

SECTION IX -- INDUSTRY STRUCTURE

  • 1 US Nanotechnology Medical Product Sales by Company, 2009
  • 2 Selected Cooperative Agreements
  • 3 Selected Acquisitions & Divestitures

LIST OF CHARTS

SECTION II -- MARKET ENVIRONMENT

  • Medical Products Demand by Group, 2009

SECTION III -- MEDICAL NANOMATERIALS

  • Medical Nanomaterials Demand by Type, 2009

SECTION IV -- NANOTECHNOLOGY HEALTH CARE OVERVIEW

  • Nanotechnology Medical Products Demand by Group, 2009

SECTION V -- NANOMEDICINES

  • Nanomedicines Demand by Product Group, 2009

SECTION VI -- NANODIAGNOSTICS

  • Nanodiagnostics Demand by Product Group, 2009

SECTION VII -- NANOTECHNOLOGY MEDICAL SUPPLIES & DEVICES

  • Nanotechnology Medical Supplies & Devices Demand by Product Group, 2014

SECTION VIII -- APPLICATIONS

  • Nanotechnology Medical Products Demand by Application, 2009

SECTION IX -- INDUSTRY STRUCTURE

  • Nanotechnology Medical Products Market Share by Company, 2009
Back to Top